期刊文献+

胺碘酮治疗老年慢性心力衰竭合并室性心律失常84例临床观察 被引量:2

Clinical observation of amiodarone in the treatment of chronic heart failure complicated by ventricular arrhythmias in 84 cases of senile patients
在线阅读 下载PDF
导出
摘要 目的:观察胺碘酮治疗老年人心力衰竭合并室性心律失常的有效性和安全性。方法:对84例慢性心力衰竭并发有症状的室性心律失常患者,经常规抗心力衰竭治疗病情稳定后,给予口服胺碘酮0.2 g,每日3次,连服5~7天,然后改为0.2 g,每日2次,连服l周,之后以0.1~0.2 g,每日l次维持,疗程8周,应用24小时动态心电图、超声心动图评价治疗室性心律失常效果、心功能变化、心率、QT间期变化和不良反应。结果:治疗后84例患者中,心功能提高1级者占84%,室性心律失常治疗总有效率为74%,其中显效39例(46%),有效24例(28%),心率显著降低,QT间期延长。用药后有4例出现窦性心动过缓,经减量或停药后恢复。治疗前后左室射血分数(LVEF)差异有统计学意义(P〈0.001),未出现严重不良反应。结论:胺碘酮治疗老年人慢性心力衰竭合并室性心律失常是有效和安全的。 Objective: 84 patients with chronic heart failure complicated with symptomatic ventricular arrhythmia were selected in this study. Methods:After effective conventional treatment against heart failure, the patients were assigned to receive oral amiodarone by 0.2 g, 3 times a day for 5 - 7 days, then the 0.2 g, twice a day for a week, followed by 0.1 -0.2 g, once a day for 8 weeks or on a long-term basis. Before and after the treatment the heart function, improvement of VA, heart rate, change of Q-T internal and side-effect were observed. Results : After the treatment, among 84 patients, the patients whose heart function was elevated by 1 grade accounted for84 % , and the total effective rate for VA was 74% , including obvious effective rate 46% and effective rate 29%. There also was a significant decrease of heart rate and a slight prolongation of Q-T internal. With regard to the side-effect, sinus bradycardia was found in4eases, which disappeared after withdrawal or decrease of administration. Conclusion: On the basis of positive treatment against heart failure, the administration of amiodarone for senile patients with heart failure complicated by VA is effective and safe.
作者 任培龙
出处 《河南医学研究》 CAS 2009年第3期225-227,共3页 Henan Medical Research
关键词 胺碘酮 老年人 慢性心力衰竭 室性心律失常 senile people ventricular arrhythmia amiodarone congestive heart failure
  • 相关文献

参考文献6

二级参考文献67

  • 1郭林妮,黄元铸,蒋文平,李庚山,陆再英,戚文航,任自文,吴宁,向晋涛,朱俊,方圻,高润霖.胺碘酮抗心律失常治疗应用指南[J].中国心脏起搏与心电生理杂志,2004,18(6):401-407. 被引量:392
  • 2康健,高秉新,范丽文,陈捷,闫立荣,张宁.胺碘酮对室性心律失常患者QT离散度的影响[J].中华老年心脑血管病杂志,2000,2(2):89-91. 被引量:15
  • 3王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:91
  • 4Chun S H,Am J Cardiol,1995年,76卷,47页
  • 5Goldschlager N, Epstein A E, Naccarlli G, et al. Practical guidelines for clinicians, Who treat patients with amiodarone[J]. Arch Intem Med,2000,160: 1 741.
  • 6Siddoway L A. Amiodarone: Guidelines for use and monitoring[J]. Am Fam physician,2003,68: 2 189.
  • 7Kodana I, Kamiyak, Toyama J.Callular electropharmacology of amiodarone[J].Carodiovascular Research,1997,35: 13.
  • 8Kamiya K, Cheng J,Kodama I,et al. Modulation of repolarizaing Potassium channels and Kv1.5 mRNA by long-term treatment with amiodarone[J]. Circulation,1995,92(S1):373.
  • 9Vitolo E, Tronci M, Larovere MT,et al. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation[J]. Acta Cardiol, 1981,36: 431.
  • 10Zehender M, Hohnloser S, Müller B,et al.Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrillation results of a comparative study and a 2-year follow up[J]. J A CC,1992,19: 1 054.

共引文献3919

同被引文献11

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部